ArticleHealth science reports2025
Epidemiology of the Incidence, Prevalence, and Mortality of Thalassemia in Iran: A Secondary Analysis of Global Burden of Disease 2019.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The Prevalence of Anxiety in Patients With Beta-Thalassaemia Major: A Systematic Review and Meta-Analysis.Nursing open · 2026Pooled it
- A Scoring System for the Assessment of Quality of Care in the Management of Transfusion Dependent Thalassemia.Hematology reports · 2026Review
- Comparative study of hemoglobin changes following transfusion of fresh and old blood in patients with thalassemia referred to Bahrami Hospital.BMC pediatrics · 2026Article
- The emergence of autochthonous dengue fever in Iran: a comprehensive analysis of the first major outbreak in Sistan and Baluchestan Province, 2024.BMC infectious diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Compared to other regions, Iran is one of the countries where the prevalence of thalassemia is higher. The purpose of the present study is to investigate the epidemiology of the incidence, prevalence, and mortality of thalassemia in Iran. Methods: The present study is a correlation analysis. Age-standardized data on incidence, mortality, and prevalence per 100,000 populations for thalassemia in Iran were extracted from the World Burden of Disease 2019 website. ArcGIS version 10.8 was also used to draw the types of zoning. Pearson correlation tests have been used to investigate the relationship between these indicators and the human development index. Data analysis was conducted using Stata-14 at a significance level of 0.05. Results: The results have indicated that the rate of change in mortality in 2019 was negative compared to that of 2010, indicating a decrease in the mortality rate of this disease for both males and females. The highest death rate from thalassemia disease in both genders was related to age groups less than 5 years old. The results showed that there is a negative and significant correlation between the incidence rate and the human development index ( Conclusion: Considering the distribution of the disease in the country, prevention of new cases is the best way to control this disease. The attention of the health policy makers to reduce the incidence rate by improving the cultural, social, and economic conditions in many regions of the country will help the prevention of the incidence of the disease. Public education, genetic counseling, and pre-pregnancy care can play a significant role in controlling the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.